Clinical Trial Update: Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating percutaneous electric neurostimulation of dermatome T7 in obese patients with type 2 diabetes shows an improvement in glycemic profil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospital General Universitario Elche | Conditions: Diabetes Mellitus Type 2 in Obese, Type 2 Diabetes Mellitus With Features of Insulin Resistance | Phase 3 | Status: COMPLETED